GE Healthcare has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest version of its Vivid E9 cardiovascular ultrasound system.
Vivid E9 Breakthrough 2011 (BT11) includes new features aimed at improving image quality, quantification, and workflow, according to the Chalfont St. Giles, U.K.-based vendor.
BT11 features dynamic multislice acquisition technology, with the ability to acquire images of up to 12 slices of the heart, GE said. Automated function imaging (AFI) provides triplane measurements.
In addition, BT11 includes new quantification tools such as 4D strain, 2D auto EF, and AFI for transesophageal echocardiography (TEE) for left ventricular, global, and regional function, GE said.
GE said it has also included new transducers, including a high-bandwidth 4V-D transducer with improved 2D and 4D image quality and the ability to scan in all modes; a new 12S-D transducer for neonatal patients; a ML6-15-D probe for shared services; and an intraoperative i13L probe.
Related Reading
GE, UPMC test digital pathology, October 28, 2010
GE preps upgrades for ICD-10 codes, October 26, 2010
GE debuts follicle ultrasound software, October 25, 2010
GE to buy Clarient for $580M, October 22, 2010
GE's DaTSCAN gets European nod, October 15, 2010
Copyright © 2010 AuntMinnie.com
